Establishing secure connection…Loading editor…Preparing document…

Research Alcohol Study

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH ALCOHOL STUDY AGREEMENT

This Research Alcohol Study Agreement (Agreement) is entered into as of by and between Sponsor Name: and Research Institution Name: .

WHEREAS

WHEREAS, Sponsor is engaged in funding clinical and behavioral research and desires to sponsor a study concerning alcohol use, effects, and related behavioral metrics (Study); and

WHEREAS, Research Institution possesses the personnel, facilities, and regulatory approvals necessary to conduct human-subjects research in accordance with applicable standards and the Study protocol; and

WHEREAS, the parties wish to set forth their respective rights and obligations with respect to the conduct, funding, data handling, and reporting of the Study.

SCOPE OF WORK

Research Institution will perform the Study in accordance with the protocol titled and the Scope of Work described below. The Scope of Work includes recruitment and screening of participants, informed consent procedures, administration of study interventions and assessments, data collection and de-identification, and submission of interim and final reports to Sponsor.

PAYMENT TERMS

Sponsor agrees to compensate Research Institution as follows. All amounts are in U.S. dollars and are exclusive of taxes unless expressly stated.

TERM AND TERMINATION

This Agreement commences on Start Date: and, unless earlier terminated in accordance with this Agreement, continues until End Date: .

Either party may terminate this Agreement for material breach by the other party if the breaching party fails to cure the breach within days after receipt of written notice specifying the breach. Sponsor may terminate for convenience upon days' prior written notice to Research Institution, subject to payment for work performed through the effective date of termination and reasonable wind‑down costs.

CONFIDENTIALITY

"Confidential Information" means nonpublic information disclosed by either party relating to the Study, participant data, business operations, or proprietary methods. Each party shall: (a) hold Confidential Information in strict confidence; (b) use Confidential Information solely to perform its obligations under this Agreement; and (c) restrict disclosure to employees, contractors, or agents who have a need to know and are bound by confidentiality obligations at least as protective as those herein.

Research Institution shall implement administrative, technical, and physical safeguards reasonably designed to protect participant data from unauthorized access. Personal data provided to Sponsor shall be de-identified unless explicit written consent for identifiable data transfer is obtained from participants. Confidentiality obligations shall survive termination of this Agreement for years.

DATA OWNERSHIP, PUBLICATION, AND INTELLECTUAL PROPERTY

Unless otherwise agreed in writing, Sponsor shall own the Study funding-related deliverables and datasets provided to Sponsor in identifiable or de‑identified form as specified in this Agreement. Research Institution shall retain ownership of its pre-existing intellectual property and methods. Parties agree to coordinate on manuscript submission and public disclosure; no publication that includes the other party's Confidential Information shall be made without thirty (30) days' prior notice and an opportunity for comment.

INDEMNIFICATION

Each party shall indemnify and hold harmless the other party from and against any third-party claims arising from the indemnifying party's willful misconduct or material breach of this Agreement, subject to the indemnified party's prompt written notice and reasonable cooperation in the defense and settlement of such claims.

GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the State of , without regard to its conflict of laws principles.

ENTIRE AGREEMENT

This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, and communications, whether written or oral. Any amendment or modification of this Agreement must be in writing and signed by authorized representatives of both parties.

NOTICES

All notices required under this Agreement shall be in writing and delivered to the addresses set forth above or such other address as a party may specify in writing. Notices shall be effective upon receipt.

Sponsor:

By:

Date:

Research Institution:

By:

Date:

Enter text✕

What the Research Alcohol Study document is

Research Alcohol Study is a standardized participant-facing document used in clinical and behavioral research to record informed consent, baseline data, and study-specific permissions related to alcohol consumption and treatment protocols. It outlines study purpose, procedures, risks, benefits, confidentiality protections, data sharing, and contact information for investigators and institutional review boards. The document can include medical history screens, screening questionnaires, and authorization for use of protected health information. When executed correctly it establishes participant understanding, documents voluntary agreement, and serves as the legal record for enrollment and regulatory compliance.

Common questions and practical answers

Answers to common questions about completing, signing, and managing the Research Alcohol Study form, including eSignature and HIPAA considerations.


Need help? Contact support

Step-by-step: completing and executing the form

Practical sequential steps to complete and execute the Research Alcohol Study consent and intake form, from preparation through certified storage.

  • 01
    Prepare documents: Gather protocol, consent, screening tools, and IRB-approved versions before contacting participants.
  • 02
    Verify eligibility: Screen age, medical history, and alcohol use criteria per protocol.
  • 03
    Obtain consent: Provide disclosures, answer questions, then collect signed consent via eSign or wet signature.
  • 04
    Secure records: Store signed forms in secure, access-controlled systems with audit trails and retention policies.

Who typically prepares and signs these forms

Researchers, study coordinators, and institutional review boards commonly use the Research Alcohol Study consent and intake forms.

  • Academic investigators use the form to document consent, eligibility screening, and subject contact information.
  • Clinical trial coordinators rely on standardized fields for scheduling, adverse event tracking, and regulatory reporting.
  • Healthcare providers involved in behavioral interventions collect medical histories and HIPAA authorizations using this document.

Sponsors, data managers, and clinical staff rely on completed forms for monitoring, audits, and regulatory documentation during study lifecycle.

Why using a standardized Research Alcohol Study form matters

Using a standardized Research Alcohol Study consent document clarifies participant rights, reduces administrative errors, and improves regulatory compliance by documenting informed consent, eligibility checks, and data-sharing permissions in a single record usable for monitoring, audit readiness, and consistent study conduct.

Why using a standardized Research Alcohol Study form matters

Key components of a professional Research Alcohol Study form

Core components and features of a professional Research Alcohol Study document ensure legal clarity, participant protection, data quality, and compatibility with electronic workflows.

Consent Elements

Clear description of purpose, procedures, duration, risks, benefits, voluntary participation, and withdrawal rights. Consent language must be understandable and IRB-approved to satisfy 45 CFR §46 requirements.

Privacy

PHI handling, data de-identification, and storage controls described. Include HIPAA authorization language where PHI is collected; reference 45 CFR §164 series for safeguards. Also specify data access and third-party sharing limitations.

Screening

Standardized eligibility questions and alcohol use screening tools (e.g., AUDIT) should be included. Document scoring rules and thresholds used for enrollment decisions. Retain raw responses for auditing.

Signatures

Signature block that accommodates wet signatures and electronic signing. Audit trail must capture signer identity, timestamp, IP address, and method to support ESIGN and IRB documentation.

Data Fields

Structured fields for demographics, medical history, medication lists, and standardized alcohol consumption metrics enable consistent data capture and simplify export to analysis-ready datasets with variable coding standards noted.

eConsent Ready

Fields and disclosures formatted for electronic delivery, consent affirmation, and attachments. Ensure consumer disclosure compliance under ESIGN and document reproducibility for audit and regulatory review.

Security and compliance checklist

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest
HIPAA: Compliant with BAA required
SOC 2: SOC 2 Type II report available
21 CFR: Supports 21 CFR Part 11 controls
ESIGN/UETA: Compliant with ESIGN and UETA
Audit Trail: Detailed timestamps, IP, and user actions

Penalties and risks from incorrect documentation

Invalid Consent: May invalidate enrollment
HIPAA Violation: Civil penalties and corrective action
Data Breach: Notification and fines possible
Regulatory Sanctions: IRB suspension or reporting
Research Misconduct: Investigation, funding loss
Legal Liability: Civil suits possible

Frequent preparation and execution pitfalls

  • Incomplete identity verification can lead to ineligible participants being enrolled, compromising data integrity and triggering IRB concerns or study suspension.
  • Ambiguous consent language or missing risk disclosures increases legal exposure and may require reconsent or corrective notices to participants.
  • Failing to retain audit logs or signed copies undermines reproducibility, complicates audits, and may violate ESIGN retention expectations.
  • Using weak authentication for high-risk procedures can expose participants and institutions; stronger verification should align with IRB risk assessments.

Recommended eConsent workflow configuration

Suggested online configuration for eConsent, field validation, and secure submission in an eSignature platform used for Research Alcohol Study.

Field Configuration
Primary signer authentication method via SMS Email and SMS code with optional KBA.
Field validation rules and formats Use MM/DD/YYYY and required field flags for critical entries.
Consent disclosure and audit requirements Include ESIGN consumer disclosure and enable full audit trail capture.
Secure storage and role-based access controls Encrypted storage, least-privilege roles, and retention policies applied.
Integration options and export formats (CSV, JSON) Export to CSV or secure API for analysis-ready datasets.

Technical platform requirements for eSubmission

Platforms and technical requirements for eSubmission and eSignature of the Research Alcohol Study, including integrations and supported file formats.

  • File types: PDF, DOCX, and HTML supported
  • Integrations: Salesforce, NetSuite, Google Workspace, and Box
  • Authentication methods: Email link, SMS code, SSO options

Comparing common eSignature plans for study workflows

Comparison of common eSignature plans and core features relevant to Research Alcohol Study workflows and compliance requirements.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by offer Varies by offer Varies by offer Varies by offer
Bulk Send Yes Yes Yes Yes Varies by plan
Audit Trail Yes Yes Yes Yes Yes
Envelope Cap No envelope cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Key timing and submission milestones

Key dates and submission deadlines relevant to consent, IRB review, and reporting for Research Alcohol Study.

IRB submission deadline:

IRB approval must precede participant enrollment.

Consent documentation timing:

Obtain signed consent before any study procedures or data collection.

Adverse event reporting window:

Report serious adverse events promptly per IRB and sponsor timelines.

Data access requests:

Respond to requests within timeframes set by sponsor or law.

Record retention start date:

Retention measured from consent date unless otherwise specified.

Practical examples from field studies

Examples of how Research Alcohol Study consent and eSignature workflows operate in practical study settings.

University Behavioral Trial

A university research team used eConsent to enroll participants remotely during a field study on alcohol consumption patterns.

  • Enrollment completed with secure eSign and audit trails.
  • IRB accepted the electronic consent process after review; audit logs and identity verification met institutional requirements. The team reported faster enrollment, consistent data capture, and straightforward records requests during monitoring visits.

Community Clinic Pilot

A community clinic implemented the study to assess brief interventions; staff used a tablet-based intake and eSign workflow to consent patients.

  • PHI protections and HIPAA BAA were in place.
  • The clinic secured a BAA with their eSignature vendor, trained staff on authentication, and reduced appointment no-shows. Sponsors reviewed consent versions via secure portal during quarterly monitoring without needing physical files.

be ready to get more
Join over 28 million airSlate SignNow users